MDxHealth SA - ADR Financials

$0.68

$-0.02 (-2.31%)

As on 10-Sep-2026 16:11EDT

Market cap

$71 Mln

Revenue (TTM)

$164 Mln

P/E Ratio

--

P/B Ratio

23.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	163.97	107.88	90.05	70.19	37.05	22.24
Cost of Revenue	69.59	43.43	34.91	26.26	17.84	11.68
Gross Profit	94.38	64.44	55.14	43.93	19.22	10.56
Operating Expenses	134.58	79.84	79.86	71.26	57.12	37.41
Operating Profit (EBIT)	-30.88	-15.40	-24.72	-27.33	-37.90	-26.84
Other Income	--	--	--	--	--	--
Profit before Tax	-57.09	-35.38	-37.69	-43.10	-44.04	-29.00
Provision for Tax	-2.06	-1.86	0.38	0.00	6.14	1.88
Profit after Tax (Net Income)	-57.09	-33.52	-38.07	-43.10	-44.04	-29.00
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-44.04	-29.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-30.40	-12.09	14.84	7.21	9.32	46.90
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	125.09	110.51	99.83	102.40	91.54	11.74
Current Liabilities	37.40	49.53	42.66	19.52	18.28	16.43
Total Liabilities	37.40	147.95	157.33	129.13	119.14	75.07

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	89.06	94.54	90.43	90.97	89.99	8.47
Current Assets	43.03	53.41	66.90	38.16	29.15	66.61
Total Assets	169.49	147.95	157.33	129.13	119.14	75.07
Total Debt*	--	95.11	60.06	41.27	39.79	15.56
Net Current Assets	5.63	3.88	24.23	18.64	10.87	50.17

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-10.42	-18.53	-21.50	-34.12	-22.55
Cash Flow from Investing Activities	--	-20.06	-1.64	-3.93	-29.04	-0.89
Cash from Financing Activities	--	12.70	44.60	32.28	20.72	66.50
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	--	-0.67	-0.78	-1.58	-3.61	-2.38
Cash EPS ($)	--	-0.49	-0.61	-1.31	-3.21	-2.13
Adjusted Book Value ($)	--	--	0.30	0.26	0.76	3.85
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.21	-0.38	-0.79	-2.80	-1.85
Free Cash Flow per Share ($)	--	-0.23	-0.42	-0.97	-3.14	-1.92

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-42.45	-61.71	-88.34	-78.96	-68.91
ROE (%)	--	-2,440.41	-345.31	-521.70	-156.70	-109.96
ROA (%)	-32.50	-21.96	-26.58	-34.72	-45.36	-54.25
EBIT Margin (%)	-15.32	-21.52	-33.38	-53.18	-111.46	-121.98
Net Margin (%)	-34.82	-31.07	-42.28	-61.40	-118.86	-130.41
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	34.11	0.20	0.28	0.89	0.67	0.20
EBIT Growth (%)	-15.31	22.77	19.47	9.62	-52.25	0.68
Net Profit Growth (%)	-24.66	11.95	11.67	2.14	-51.87	-1.19
EPS Growth (%)	--	0.14	0.51	0.56	-0.52	0.25
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-5.33	-3.04	-2.49	-1.83	-4.00
Price / Book Value	23.64	-14.77	7.80	14.92	8.65	2.48
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	17.57	-17.47	-5.86	-4.15	-2.88	-3.03
Close Price ($)	0.41	3.57	2.37	3.94	66.10	95.20
High Price ($)	5.33	5.33	4.64	76.00	109.50	131.70
Low Price ($)	0.40	1.35	1.55	0.35	59.70	83.00
Market Cap ($ Cr)	71.41	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	-3.17	-7.86	4.05	5.72	4.27	0.33
Short term debt to equity ratio	--	-0.16	0.11	0.29	0.19	0.11
Current Ratio	1.15	1.08	1.57	1.95	1.59	4.05
Quick Ratio	0.98	0.94	1.48	1.81	1.47	3.94
Interest Coverage	-0.99	-1.91	-3.94	-6.47	-15.06	-14.47

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	9.10	13.65	16.14	16.06	25.25	20.60
Asset Turnover	0.93	0.71	0.63	0.57	0.38	0.42
Receivable days	--	49.54	52.33	53.67	68.70	69.60
Inventory Days	--	44.61	34.78	35.50	43.40	66.25
Payable days	--	77.08	87.95	132.04	180.56	199.83
Cash Conversion Cycle	--	17.07	-0.84	-42.87	-68.46	-63.98

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.